Condition: Idiopathic Short Stature · Sponsor: BioMarin Pharmaceutical
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
This description comes directly from the study's public registry record.
Trial Specialist · 18009834587 · Medinfo@bmrn.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital - Thomas Campus (Main) | Phoenix, Arizona, United States | Withdrawn |
| Children's Hospital Los Angeles | Los Angeles, California, United States | Not Yet Recruiting |
| Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed) | Los Angeles, California, United States | Recruiting |
| Children's Hospital of Orange County Main Campus - Orange | Orange, California, United States | Not Yet Recruiting |
| Center Of Excellence in Diabetes and Endocrinology | Sacramento, California, United States | Recruiting |
| Rady Children's Hospital - San Diego | San Diego, California, United States | Not Yet Recruiting |
| University of California San Francisco (UCSF) | San Francisco, California, United States | Recruiting |
| Connecticut Children's Medical Center | Hartford, Connecticut, United States | Recruiting |
| Yale School of Medicine | New Haven, Connecticut, United States | Withdrawn |
| Children's National Health System | Washington D.C., District of Columbia, United States | Recruiting |
| Nemours Children's Clinic | Jacksonville, Florida, United States | Recruiting |
| Nicklaus Children's Hospital | Miami, Florida, United States | Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06309979